Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for Opioid Reduction After Spine Surgery
NCT04562597Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Jan 2021
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial of acetylcysteine in postoperative pain (6 arms), sponsored by Medical University of South Carolina. Primary endpoint: Opioid Consumption 12 Hours Post Operative. Started Jan 2021; status: completed.
02
Drugs
acetylcysteine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04562597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04562597.